161 related articles for article (PubMed ID: 16055880)
1. Combination aerosol therapy to treat Burkholderia cepacia complex.
Middleton PG; Kidd TJ; Williams B
Eur Respir J; 2005 Aug; 26(2):305-8. PubMed ID: 16055880
[TBL] [Abstract][Full Text] [Related]
2. Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?
Ball R; Brownlee KG; Duff AJ; Denton M; Conway SP; Lee TW
J Cyst Fibros; 2010 Jan; 9(1):73-4. PubMed ID: 19932062
[No Abstract] [Full Text] [Related]
3. Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis.
Uluer AZ; Waltz DA; Kalish LA; Adams S; Gerard C; Ericson DA
J Cyst Fibros; 2013 Jan; 12(1):54-9. PubMed ID: 23046902
[TBL] [Abstract][Full Text] [Related]
4. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
Kitt H; Lenney W; Gilchrist FJ
BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy.
Weidmann A; Webb AK; Dodd ME; Jones AM
J Cyst Fibros; 2008 Sep; 7(5):409-11. PubMed ID: 18356119
[TBL] [Abstract][Full Text] [Related]
6. Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection.
Waters V; Yau Y; Beaudoin T; Wettlaufer J; Tom SK; McDonald N; Rizvi L; Klingel M; Ratjen F; Tullis E
J Cyst Fibros; 2017 Jul; 16(4):492-495. PubMed ID: 28262569
[TBL] [Abstract][Full Text] [Related]
7. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD
Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.
Garcia BA; Carden JL; Goodwin DL; Smith TA; Gaggar A; Leon K; Antony VB; Rowe SM; Solomon GM
BMC Pulm Med; 2018 Feb; 18(1):35. PubMed ID: 29444656
[TBL] [Abstract][Full Text] [Related]
9. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
Treerat P; Widmer F; Middleton PG; Iredell J; George AM
FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
[TBL] [Abstract][Full Text] [Related]
10. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Moriarty TF; McElnay JC; Elborn JS; Tunney MM
Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids.
Gilchrist FJ; Webb AK; Bright-Thomas RJ; Jones AM
J Cyst Fibros; 2012 Sep; 11(5):458-60. PubMed ID: 22551926
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of cepacia syndrome.
Grimwood K; Kidd TJ; Tweed M
J Cyst Fibros; 2009 Jul; 8(4):291-3. PubMed ID: 19411195
[No Abstract] [Full Text] [Related]
13. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.
Aaron SD; Ferris W; Henry DA; Speert DP; Macdonald NE
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313
[TBL] [Abstract][Full Text] [Related]
14. Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics.
Hasan MA; Lange CF
J Aerosol Med; 2007; 20(3):282-93. PubMed ID: 17894535
[TBL] [Abstract][Full Text] [Related]
15. A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia.
Ledson MJ; Gallagher MJ; Robinson M; Cowperthwaite C; Williets T; Hart CA; Walshaw MJ
J Aerosol Med; 2002; 15(1):51-7. PubMed ID: 12006145
[TBL] [Abstract][Full Text] [Related]
16. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
Kennedy S; Beaudoin T; Yau YC; Caraher E; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
Horsley A; Jones AM
Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
[TBL] [Abstract][Full Text] [Related]
18. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
Lekkas A; Gyi KM; Hodson ME
J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
[TBL] [Abstract][Full Text] [Related]
19. Burkholderia cepacia septicemia in a pediatric oncology patient: a pharmacotherapy challenge.
Durham SH; Lee AE; Assanasen C
Ann Pharmacother; 2012 Jun; 46(6):e16. PubMed ID: 22570430
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis.
Walsh NM; Casano AA; Manangan LP; Sinkowitz-Cochran RL; Jarvis WR
J Pediatr; 2002 Oct; 141(4):512-7. PubMed ID: 12378190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
